IRCT201112088331N1已完成未知
Evaluating the effect of cytoreductive surgery and intraperitoneal chemotherapy in the peritoneal carcinomatosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 70 years（—）
- 性别
- All
入选标准
- •Patients with primary ovarian cancer who have not been previously treated for the cancer and in whom abdominal carcinomatosis is confirmed before or during surgical interventions. Exclusion criteria: Patient dissatisfaction; Patient intolerance;Lymph node metastasis; Systemic metastasis; No cytoreductive surgery (residue less than 1 cm); PS< 80%; Age> 70 years; Adhesions which are resistant to enterolysis.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal metastasis from colorectal or appendiceal cancer: a feasibility studyPeritoneal metastasis from colorectal or appendiceal cancerJPRN-UMIN000021325ational Center for Global Health and Medicine10
已完成
2 期
A prospective interventional study for pseudomyxoma peritoneipseudomyxoma peritoneiPseudomyxoma PeritoneiJPRN-jRCTs031180254Gohda Yoshimasa75
进行中（未招募）
1 期
Assessment of cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in first or secondary platinum-resistant recurrent ovarian epithelial cancer.HIPOVA-01Patients with First or second recurrence of platin-resistant epithelial ovarian cancerMedDRA version: 20.0Level: PTClassification code 10033128Term: Ovarian cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-002480-94-FRHospices Civils de Lyon220
进行中（未招募）
1 期
Cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) in patients with peritoneal carcinomatosis from ovarian cancer , fallopian tube or primary peritoneal carcinoma : randomized clinical trial.EUCTR2011-001715-31-ESFundación para la Formación e Investigación Sanitaria de la Región de Murcia126
已完成
不适用
Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular CarcinomaHepatocellular CarcinomaNCT00820157Eastern Hepatobiliary Surgery Hospital120